1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of AKR7A3 mRNA CTD PMID:21983209 1-nitropropane decreases expression EXP 6480464 1-nitropropane results in decreased expression of AKR7A3 mRNA CTD PMID:17070881 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of AKR7A3 mRNA CTD PMID:17108234 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of AKR7A3 mRNA CTD PMID:32145629 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of AKR7A3 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of AKR7A3 mRNA CTD PMID:16054898 more ... 2,4,6-trinitrotoluene affects expression EXP 6480464 Trinitrotoluene affects the expression of AKR7A3 mRNA CTD PMID:21346803 2,4-diaminotoluene increases expression EXP 6480464 2 and 4-diaminotoluene results in increased expression of AKR7A3 mRNA CTD PMID:17070881 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of AKR7A3 mRNA CTD PMID:21346803 2,6-di-tert-butyl-4-methylphenol increases expression EXP 6480464 Butylated Hydroxytoluene results in increased expression of AKR7A3 protein CTD PMID:8198522 2,6-di-tert-butyl-4-methylphenol increases activity EXP 6480464 Butylated Hydroxytoluene results in increased activity of AKR7A3 protein CTD PMID:9328168 2,6-diaminotoluene decreases expression EXP 6480464 2 and 6-diaminotoluene results in decreased expression of AKR7A3 mRNA CTD PMID:17070881 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of AKR7A3 mRNA CTD PMID:21346803 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one increases expression EXP 6480464 Praziquantel results in increased expression of AKR7A3 mRNA CTD PMID:21813463 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of AKR7A3 mRNA CTD PMID:17070881 2-amino-4,6-dinitrotoluene affects expression EXP 6480464 2-amino-4 and 6-dinitrotoluene affects the expression of AKR7A3 mRNA CTD PMID:21346803 2-nitro-p-phenylenediamine increases expression EXP 6480464 2-nitro-4-phenylenediamine results in increased expression of AKR7A3 mRNA CTD PMID:17070881 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of AKR7A3 mRNA CTD PMID:14600272 more ... 2-nitropropane increases expression EXP 6480464 2-nitropropane results in increased expression of AKR7A3 mRNA CTD PMID:17070881 2-palmitoylglycerol increases expression ISO AKR7A3 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of AKR7A3 mRNA CTD PMID:37199045 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:20959002 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of AKR7A3 protein CTD PMID:34915118 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1 more ... CTD PMID:19162173 more ... 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of AKR7A3 mRNA CTD PMID:14600272 and PMID:23052194 4-acetylaminofluorene increases expression EXP 6480464 4-acetylaminofluorene results in increased expression of AKR7A3 mRNA CTD PMID:17070881 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of AKR7A3 mRNA CTD PMID:21346803 4-nitro-1,2-phenylenediamine increases expression EXP 6480464 1 and 2-diamino-4-nitrobenzene results in increased expression of AKR7A3 mRNA CTD PMID:17070881 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions EXP 6480464 [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA CTD PMID:22687989 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of AKR7A3 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of AKR7A3 mRNA CTD PMID:19483382 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of AKR7A3 mRNA CTD PMID:30047161 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of AKR7A3 mRNA CTD PMID:24780913 and PMID:25825206 9,10-phenanthroquinone increases reduction EXP 6480464 AKR7A3 protein results in increased reduction of 9 and 10-phenanthrenequinone CTD PMID:19168568 9,10-phenanthroquinone multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 AKR7A3 protein results in increased reduction of and affects the activity of 9 and 10-phenanthrenequinone CTD PMID:21910479 acetamide increases expression EXP 6480464 acetamide results in increased expression of AKR7A3 mRNA CTD PMID:31881176 acrolein affects metabolic processing EXP 6480464 AKR7A3 protein affects the metabolism of Acrolein CTD PMID:15019089 acrolein decreases response to substance EXP 6480464 AKR7A3 protein results in decreased susceptibility to Acrolein CTD PMID:15019089 aflatoxin B1 affects expression ISO AKR7A3 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of AKR7A3 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO AKR7A3 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of AKR7A3 mRNA CTD PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of AKR7A3 mRNA CTD PMID:14600272 more ... aflatoxin B1 decreases response to substance EXP 6480464 AKR7A3 protein results in decreased susceptibility to Aflatoxin B1 CTD PMID:8395332 aflatoxin B1 increases reduction EXP 6480464 AKR7A3 protein results in increased reduction of Aflatoxin B1 metabolite CTD PMID:19168568 aflatoxin B1 affects metabolic processing EXP 6480464 AKR7A3 protein affects the metabolism of Aflatoxin B1 CTD PMID:8395332 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of AKR7A3 mRNA CTD PMID:19483382 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of AKR7A3 mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO AKR7A3 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of AKR7A3 mRNA CTD PMID:24449571 aristolochic acid A multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of AKR7A3 mRNA CTD PMID:23912714 aristolochic acid A increases expression ISO AKR7A3 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of AKR7A3 mRNA CTD PMID:33212167 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of AKR7A3 mRNA CTD PMID:18178546 arsenous acid multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AKR7A3 protein] CTD PMID:26598702 atazanavir sulfate multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A3 mRNA CTD PMID:32152650 atazanavir sulfate decreases expression ISO AKR7A3 (Homo sapiens) 6480464 Atazanavir Sulfate results in decreased expression of AKR7A3 mRNA CTD PMID:32152650 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of AKR7A3 mRNA CTD PMID:36841081 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of AKR7A3 mRNA CTD PMID:19483382 benzene affects expression EXP 6480464 Benzene affects the expression of AKR7A3 mRNA CTD PMID:15878777 benzo[a]pyrene decreases expression ISO AKR7A3 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of AKR7A3 mRNA CTD PMID:20106945 and PMID:32234424 benzo[a]pyrene affects methylation ISO AKR7A3 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of AKR7A3 promoter CTD PMID:27901495 benzo[a]pyrene-7,8-dione multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [AKR7A3 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7 and 8-dione CTD PMID:21910479 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AKR7A3 mRNA CTD PMID:18164116 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of AKR7A3 mRNA CTD PMID:22687991 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of AKR7A3 mRNA CTD PMID:25181051 and PMID:30903817 bisphenol A decreases expression ISO AKR7A3 (Homo sapiens) 6480464 bisphenol A results in decreased expression of AKR7A3 mRNA CTD PMID:31715268 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of AKR7A3 mRNA CTD PMID:30816183 more ... bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of AKR7A3 mRNA CTD PMID:12628495 more ... buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of AKR7A3 mRNA CTD PMID:24136188 butylated hydroxyanisole increases expression EXP 6480464 Butylated Hydroxyanisole results in increased expression of AKR7A3 protein CTD PMID:8198522 cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AKR7A3 mRNA CTD PMID:29298499 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of AKR7A3 mRNA CTD PMID:25993096 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AKR7A3 mRNA CTD PMID:29298499 cafestol multiple interactions EXP 6480464 [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of AKR7A3 protein] CTD PMID:17110534 capsaicin multiple interactions EXP 6480464 Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of AKR7A3 protein] CTD PMID:20359164 carbamazepine increases expression EXP 6480464 Carbamazepine results in increased expression of AKR7A3 mRNA CTD PMID:17381134 chenodeoxycholic acid decreases expression ISO AKR7A3 (Homo sapiens) 6480464 Chenodeoxycholic Acid results in decreased expression of AKR7A3 mRNA CTD PMID:27174168 chenodeoxycholic acid multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A3 mRNA more ... CTD PMID:32152650 and PMID:33819548 chloroform increases expression EXP 6480464 Chloroform results in increased expression of AKR7A3 mRNA CTD PMID:21813463 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons more ... CTD PMID:30744511 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of AKR7A3 mRNA CTD PMID:18246545 more ... clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of AKR7A3 mRNA CTD PMID:12011481 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of AKR7A3 mRNA CTD PMID:19483382 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of AKR7A3 mRNA and cobaltous chloride results in increased expression of AKR7A3 protein CTD PMID:24386269 cocaine affects expression EXP 6480464 Cocaine affects the expression of AKR7A3 mRNA CTD PMID:20187946 copper(II) sulfate decreases expression ISO AKR7A3 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of AKR7A3 mRNA CTD PMID:19549813 coumarin increases expression EXP 6480464 coumarin results in increased expression of AKR7A3 mRNA CTD PMID:18480146 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of AKR7A3 mRNA CTD PMID:26577399 and PMID:27523638 cyclosporin A decreases expression ISO AKR7A3 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of AKR7A3 mRNA CTD PMID:20106945 and PMID:25562108 cyclosporin A multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A3 mRNA CTD PMID:32152650 deoxycholic acid multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A3 mRNA more ... CTD PMID:32152650 and PMID:33819548 Diallyl sulfide increases expression EXP 6480464 allyl sulfide results in increased expression of AKR7A3 mRNA CTD PMID:19695238 diarsenic trioxide multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AKR7A3 protein] CTD PMID:26598702 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of AKR7A3 mRNA CTD PMID:21266533 dichlorvos increases expression EXP 6480464 Dichlorvos results in increased expression of AKR7A3 mRNA CTD PMID:21813463 diuron increases expression EXP 6480464 Diuron results in increased expression of AKR7A3 mRNA CTD PMID:25152437 emodin decreases activity ISO AKR7A3 (Homo sapiens) 6480464 Emodin results in decreased activity of AKR7A3 protein CTD PMID:35065925 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of AKR7A3 mRNA CTD PMID:29391264 ethanol decreases expression ISO AKR7A3 (Homo sapiens) 6480464 Ethanol results in decreased expression of AKR7A3 protein CTD PMID:20621659 ethoxyquin increases expression EXP 6480464 Ethoxyquin results in increased expression of AKR7A3 mRNA and Ethoxyquin results in increased expression of AKR7A3 protein CTD PMID:19695238 more ... ethoxyquin increases activity EXP 6480464 Ethoxyquin results in increased activity of AKR7A3 protein CTD PMID:9328168 etofenprox multiple interactions EXP 6480464 [ethofenprox co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA CTD PMID:22467020 felbamate increases expression EXP 6480464 felbamate results in increased expression of AKR7A3 mRNA CTD PMID:17381134 finasteride increases expression EXP 6480464 Finasteride results in increased expression of AKR7A3 mRNA CTD PMID:24136188 fipronil increases expression EXP 6480464 fipronil results in increased expression of AKR7A3 mRNA CTD PMID:23962444 fluconazole increases expression EXP 6480464 Fluconazole results in increased expression of AKR7A3 mRNA CTD PMID:16643972 flutamide increases expression EXP 6480464 Flutamide results in increased expression of AKR7A3 mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of AKR7A3 mRNA CTD PMID:24793618 furan increases methylation EXP 6480464 furan results in increased methylation of AKR7A3 gene CTD PMID:22079235 furan increases expression EXP 6480464 furan results in increased expression of AKR7A3 mRNA CTD PMID:15120968 more ... gabapentin increases expression EXP 6480464 gabapentin results in increased expression of AKR7A3 mRNA CTD PMID:17381134 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of AKR7A3 mRNA CTD PMID:17785943 gemfibrozil affects expression EXP 6480464 Gemfibrozil affects the expression of AKR7A3 mRNA CTD PMID:12011481 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of AKR7A3 protein CTD PMID:21081137 and PMID:22061828 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of AKR7A3 mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of AKR7A3 mRNA CTD PMID:24136188 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of AKR7A3 mRNA CTD PMID:15345336 and PMID:20621112 glycochenodeoxycholic acid multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A3 mRNA more ... CTD PMID:32152650 and PMID:33819548 glycocholic acid multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A3 mRNA more ... CTD PMID:32152650 and PMID:33819548 glycodeoxycholic acid multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A3 mRNA more ... CTD PMID:32152650 and PMID:33819548 indole-3-methanol increases activity EXP 6480464 indole-3-carbinol results in increased activity of AKR7A3 protein CTD PMID:9328168 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA CTD PMID:22129741 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of AKR7A3 mRNA CTD PMID:21396975 kahweol multiple interactions EXP 6480464 [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of AKR7A3 protein] CTD PMID:17110534 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of AKR7A3 mRNA CTD PMID:19483382 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of AKR7A3 mRNA CTD PMID:22641619 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [[Diethylnitrosamine co-treated with oxfendazole] results in increased expression of AKR7A3 mRNA] CTD PMID:20033131 mercury atom multiple interactions EXP 6480464 [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of AKR7A3 mRNA and [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of AKR7A3 protein CTD PMID:29298499 mercury dichloride multiple interactions EXP 6480464 [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of AKR7A3 mRNA and [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of AKR7A3 protein CTD PMID:29298499 mercury(0) multiple interactions EXP 6480464 [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of AKR7A3 mRNA and [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of AKR7A3 protein CTD PMID:29298499 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of AKR7A3 mRNA CTD PMID:15120968 more ... methimazole increases expression EXP 6480464 Methimazole results in increased expression of AKR7A3 mRNA CTD PMID:30047161 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons more ... CTD PMID:30744511 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AKR7A3 mRNA more ... CTD PMID:18164116 more ... N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of AKR7A3 mRNA CTD PMID:19638242 and PMID:21813463 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of AKR7A3 mRNA CTD PMID:11323195 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of AKR7A3 mRNA CTD PMID:14600272 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of AKR7A3 mRNA and N-nitrosomorpholine results in increased expression of AKR7A3 protein CTD PMID:19716841 NADP zwitterion multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [AKR7A3 protein co-treated with NADP] results in increased reduction of and affects the activity of 4-hydroxyequilenin-o-quinone more ... CTD PMID:21910479 NADP(+) multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [AKR7A3 protein co-treated with NADP] results in increased reduction of and affects the activity of 4-hydroxyequilenin-o-quinone more ... CTD PMID:21910479 naphthalene increases expression EXP 6480464 naphthalene analog results in increased expression of AKR7A3 mRNA CTD PMID:24976557 naphthalenes multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 AKR7A3 protein results in increased reduction of and affects the activity of Naphthalenes CTD PMID:21910479 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of AKR7A3 mRNA CTD PMID:24136188 nefazodone decreases expression ISO AKR7A3 (Homo sapiens) 6480464 nefazodone results in decreased expression of AKR7A3 mRNA CTD PMID:32152650 nefazodone multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A3 mRNA CTD PMID:32152650 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of AKR7A3 mRNA CTD PMID:24136188 O-methyleugenol decreases expression ISO AKR7A3 (Homo sapiens) 6480464 methyleugenol results in decreased expression of AKR7A3 mRNA CTD PMID:32234424 ochratoxin A multiple interactions EXP 6480464 [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of AKR7A3 protein] CTD PMID:17110534 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of AKR7A3 mRNA and ochratoxin A results in decreased expression of AKR7A3 protein CTD PMID:16251485 and PMID:17110534 oltipraz increases activity EXP 6480464 oltipraz results in increased activity of AKR7A3 protein CTD PMID:9328168 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of AKR7A3 mRNA CTD PMID:19483382 omeprazole multiple interactions EXP 6480464 [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA CTD PMID:22687989 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of AKR7A3 mRNA CTD PMID:23665939 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of AKR7A3 mRNA CTD PMID:25729387 oxfendazole multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of AKR7A3 mRNA more ... CTD PMID:18754104 and PMID:20033131 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of AKR7A3 mRNA CTD PMID:27638505 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of AKR7A3 mRNA CTD PMID:15120968 more ... paracetamol multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of AKR7A3 mRNA CTD PMID:33819548 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of AKR7A3 mRNA CTD PMID:19162173 phenethyl isothiocyanate increases expression EXP 6480464 phenethyl isothiocyanate results in increased expression of AKR7A3 mRNA CTD PMID:17616710 phenethyl isothiocyanate increases activity EXP 6480464 phenethyl isothiocyanate results in increased activity of AKR7A3 protein CTD PMID:9328168 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of AKR7A3 mRNA CTD PMID:12011481 more ... phenytoin decreases expression EXP 6480464 Phenytoin results in decreased expression of AKR7A3 mRNA CTD PMID:17381134 phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of AKR7A3 mRNA CTD PMID:17381134 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of AKR7A3 mRNA CTD PMID:18544911 and PMID:22484513 piperonyl butoxide multiple interactions EXP 6480464 Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of AKR7A3 mRNA] CTD PMID:18544911 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of AKR7A3 mRNA CTD PMID:19162173 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of AKR7A3 mRNA CTD PMID:12011481 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of AKR7A3 mRNA CTD PMID:19483382 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of AKR7A3 mRNA CTD PMID:19162173 and PMID:30047161 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of AKR7A3 mRNA CTD PMID:16643972 pyrazinecarboxamide increases expression EXP 6480464 Pyrazinamide results in increased expression of AKR7A3 mRNA CTD PMID:22431067 quercetin affects expression EXP 6480464 Quercetin affects the expression of AKR7A3 mRNA CTD PMID:18178720 quercetin increases expression EXP 6480464 Quercetin results in increased expression of AKR7A3 mRNA CTD PMID:19191009 quercetin 3-O-beta-D-glucofuranoside multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of AKR7A3 mRNA CTD PMID:20033131 quercetin 3-O-beta-D-glucopyranoside multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of AKR7A3 mRNA CTD PMID:20033131 sinigrin increases activity EXP 6480464 sinigrin results in increased activity of AKR7A3 protein CTD PMID:9328168 sodium arsenite increases expression ISO AKR7A3 (Homo sapiens) 6480464 sodium arsenite results in increased expression of AKR7A3 mRNA CTD PMID:34032870 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of AKR7A3 mRNA CTD PMID:25993096 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of AKR7A3 mRNA CTD PMID:25905778 succinic semialdehyde affects metabolic processing EXP 6480464 AKR7A3 protein affects the metabolism of succinic semialdehyde CTD PMID:15019089 Sunset Yellow FCF multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of AKR7A3 mRNA CTD PMID:33819548 tartrazine multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A3 mRNA CTD PMID:33819548 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of AKR7A3 mRNA CTD PMID:31150632 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of AKR7A3 mRNA CTD PMID:19483382 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of AKR7A3 mRNA CTD PMID:28943392 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of AKR7A3 mRNA CTD PMID:23411599 and PMID:34492290 toluene affects expression EXP 6480464 Toluene affects the expression of AKR7A3 mRNA CTD PMID:18653662 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of AKR7A3 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of AKR7A3 mRNA CTD PMID:25729387 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of AKR7A3 mRNA CTD PMID:16643972 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of AKR7A3 mRNA CTD PMID:19448997 and PMID:33387578 triclosan multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in decreased expression of AKR7A3 mRNA CTD PMID:33819548 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of AKR7A3 mRNA CTD PMID:30589522 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of AKR7A3 mRNA CTD PMID:24136188 umbelliferone increases expression ISO AKR7A3 (Homo sapiens) 6480464 7-hydroxycoumarin results in increased expression of AKR7A3 mRNA CTD PMID:28263721 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of AKR7A3 mRNA CTD PMID:24136188 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of AKR7A3 mRNA CTD PMID:17381134 and PMID:23665938